跳至主要内容
临床试验/DRKS00030346
DRKS00030346已完成未知

Investigation of matrix metalloproteinase-9 levels in dental pulp blood as a marker for the inflammatory state of the pulp tissue - a prospective clinical pilot study

Poliklinik für ZahnerhaltungskundeUniversitätsklinikum Heidelberg0 个研究点目标入组 44 人开始时间: 2022年10月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
12 Years 至 one(—)
性别
All

入选标准

  • Male and female patients of the age = 12 years
  • - Patients from the Department of Conservative Dentistry at Clinic for Oral, Dental and Maxillofacial Diseases, University Hospital Heidelberg or from one of the cooperating trial centres
  • - Present declaration of consent of the patient to participate in the study; in the case of underage patients, the consent of the legal guardian/legal representative must also be present
  • - Adult patients must be able to give consent
  • - Teeth in which (the clearly vital) pulp of a tooth with a caries extending into the pulp resulting in pulp exposure during caries excavation.
  • - The pulp tissue of the treated tooth must be classified either as completely asymptomatic, reversibly inflamed (reversible pulpitis) or irreversibly inflamed (irreversible pulpitis).
  • - The tooth must be treatable and restorable under rubber dam isolation.
  • - The restoration of the tooth after partial pulpotomy and subsequent direct pulp capping with ProRoot MTA® using composite must be completed within 24 hours.

排除标准

  • - Primary teeth
  • - Patients whose state of health is reduced to such an extent that they are not able to cope with the usual stress (e.g. immunocompromised patients)
  • - Patients for the period of their pregnancy
  • - Patients who have not yet reached the age of 12
  • - Patients who do not give their consent to participate in the study
  • - Patients who have taken antibiotics in the last four weeks
  • - Patients who have taken medicaments with a potential influence on the MMP-9 level, e.g. bisphosphonates, statins, acetylsalicylic acid (exception is group 3, in which patients have taken the NSAID Ibuprofen)
  • - Teeth that have a longitudinal fracture at the time of the treatment with partial pulpotomy
  • - Teeth which, at the time of the treatment, showed bone loss down to the apical third of the root, teeth with a perio-endo-lesion or teeth with a degree of mobility of 3
  • - Teeth that showed at the periapical radiograph a periapical index PAI=2 at the day of the treatment (arm 1 and 2 with partial pulpotomy)
  • - Teeth that showed at the periapical radiograph a periapical index PAI>2 at the day of the treatment (arm 3 and 4 with root canal treatment). Teeth in which an internal or external tooth/root resorption is already evident at day of the treatment with partial pulpotomy,
  • - Teeth that could not be assigned unequivocally to one of the four diagnostic groups after clinical and radiographic examination

研究者

发起方
Poliklinik für ZahnerhaltungskundeUniversitätsklinikum Heidelberg

相似试验

Investigation of matrix metalloproteinase-9 levels... | 临床试验